Literature DB >> 34826396

Molecular basis of the anticancer, apoptotic and antibacterial activities of Bombyx mori Cecropin A.

Francisco Ramos-Martín1, Claudia Herrera-León2, Nicola D'Amelio3.   

Abstract

As Cecropin XJ, Cecropin A from Bombyx mori is one of the very few antimicrobial peptides having shown activity against esophageal cancer cells. It displays remarkable sequence-similarity to Cecropin XJ but slightly enhanced activity. In this work we show by NMR that both peptides are unstructured in solution but get structured in the presence of DPC micelles, mimicking the surface of biological membranes. In order to get insight into the molecular basis of its anticancer, antimicrobial and antifungal activity, we have investigated by MD simulations their interaction with a large variety of lipid bilayers mimicking cancer, mitochondrial, bacterial and fungal membranes. At variance with CecXJ, organized in two main helices, CecA tends to form a three helix bundle resulting in enhanced adaptability to its membrane targets. A specificity for the headgroup of phosphatidylserine and affinity for phosphatidylglycerol and cardiolipin may account for its selective targeting of cancer, bacterial and mitochondrial membranes, respectively.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Anticancer; Antimicrobial peptide; Esophageal carcinoma; Molecular dynamics; NMR

Mesh:

Substances:

Year:  2021        PMID: 34826396     DOI: 10.1016/j.abb.2021.109095

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  1 in total

1.  The Influence of Short Motifs on the Anticancer Activity of HB43 Peptide.

Authors:  Claudia Herrera-León; Francisco Ramos-Martín; Hassan El Btaouri; Viviane Antonietti; Pascal Sonnet; Laurent Martiny; Fabrizia Zevolini; Chiara Falciani; Catherine Sarazin; Nicola D'Amelio
Journal:  Pharmaceutics       Date:  2022-05-19       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.